267 related articles for article (PubMed ID: 35729457)
1. Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.
Naik PP; Desai MB
Oncol Ther; 2022 Dec; 10(2):317-335. PubMed ID: 35729457
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Management of Basal Cell Carcinoma.
Tanese K
Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
[TBL] [Abstract][Full Text] [Related]
3. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma.
Patel PV; Pixley JN; Dibble HS; Feldman SR
Dermatol Ther (Heidelb); 2023 Sep; 13(9):1959-1971. PubMed ID: 37531073
[TBL] [Abstract][Full Text] [Related]
5. Beyond Mohs surgery and excisions: A focused review of treatment options for subtypes of basal cell carcinoma.
Altun E; Schwartzman G; Cartron AM; Khachemoune A
Dermatol Ther; 2021 Jan; 34(1):e14476. PubMed ID: 33125804
[TBL] [Abstract][Full Text] [Related]
6. Advances in the management of basal cell carcinoma.
Lewin JM; Carucci JA
F1000Prime Rep; 2015; 7():53. PubMed ID: 26097726
[TBL] [Abstract][Full Text] [Related]
7. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
Rowe DE; Carroll RJ; Day CL
J Dermatol Surg Oncol; 1989 Apr; 15(4):424-31. PubMed ID: 2925988
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma. Choosing the best method of treatment for a particular lesion.
Hacker SM; Browder JF; Ramos-Caro FA
Postgrad Med; 1993 Jun; 93(8):101-4, 106-8, 111. PubMed ID: 8506171
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological study.
Dika E; Fanti PA; Ismaili A; Misciali C; Vaccari S; Barisani A; Patrizi A
J Dermatolog Treat; 2013 Jun; 24(3):238-42. PubMed ID: 23216407
[TBL] [Abstract][Full Text] [Related]
10. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
12. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
13. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma.
Chen OM; Kim K; Steele C; Wilmas KM; Aboul-Fettouh N; Burns C; Doan HQ; Silapunt S; Migden MR
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954384
[TBL] [Abstract][Full Text] [Related]
14. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
15. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
17. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
Marmur ES; Schmults CD; Goldberg DJ
Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.
Gompertz-Mattar M; Perales J; Sahu A; Mondaca S; Gonzalez S; Uribe P; Navarrete-Dechent C
Arch Dermatol Res; 2022 Oct; 314(8):777-786. PubMed ID: 34647186
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.
Marzuka AG; Book SE
Yale J Biol Med; 2015 Jun; 88(2):167-79. PubMed ID: 26029015
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
